Senza categoria Archives - Page 3 of 13 - Elixi International

3 February 2023

Find Elixi at Arab Health!

16 January 2023

Fabio Macchi is our new Head of Medical and Quality Departments.

30 March 2022

Carvykti (ciltacabtagene autoleucel), new gene therapy to treat adult patients with multiple myeloma

11 March 2022

Jardiance (empagliflozin)approved for Wider Range of Patients with Heart Failure

9 March 2022

Kimmtrak (tebentafusp), a monotherapy for the treatment of adult patients with uveal melanoma, a rare type of eye cancer.

7 February 2022

Breyanzi (lisocabtagene maraleucel) New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma

3 November 2021

Cyltezo(adalimumab-adbm), the First Interchangeable Biosimilar to Humira

25 October 2021

Trodelvy (sacituzumab govitecan), First-in-class medicine to treat aggressive form of breast cancer

21 September 2021

Byooviz (ranibizumab-nuna), First Biosimilar to Treat Macular Degeneration Disease and Other Eye Conditions

18 June 2021

Astepro (azelastine hydrochloride nasal spray, 0.15%), nasal antihistamine approved for nonprescription use